SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1535 4970 srt2:(2015-2019)"

Sökning: L773:1535 4970 > (2015-2019)

  • Resultat 1-10 av 102
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  • Batista Borges, João, 1966- (författare)
  • The Plausibility of "Bronchiolotrauma"
  • 2018
  • Ingår i: American Journal of Respiratory and Critical Care Medicine. - : AMER THORACIC SOC. - 1073-449X .- 1535-4970. ; 197:8, s. 1086-1087
  • Tidskriftsartikel (refereegranskat)
  •  
7.
  •  
8.
  • Beeh, Kai M, et al. (författare)
  • How Do Dual Long-acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?
  • 2017
  • Ingår i: American Journal of Respiratory and Critical Care Medicine. - 1073-449X .- 1535-4970. ; 196:2, s. 139-149
  • Forskningsöversikt (refereegranskat)abstract
    • Decreasing the frequency and severity of exacerbations is one of the main goals of treatment for patients with chronic obstructive pulmonary disease (COPD). Several studies have documented that long-acting bronchodilators (LABDs) can reduce exacerbation rate and/or severity, and others have shown that combinations of long-acting β2-adrenergic agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) provide greater reductions in exacerbation frequency than either their monocomponents or LABA/inhaled corticosteroids (LABA/ICS) combinations in patients at low and high risk for these events. In this review, small groups of experts critically evaluated mechanisms potentially responsible for the increased benefit of LABA/LAMA combinations over single LABDs or LABA/ICS in decreasing exacerbation. These included effects on lung hyperinflation and mechanical stress, inflammation, excessive mucus production with impaired mucociliary clearance, and symptom severity. The data assembled and analyzed by each group were reviewed by all authors and combined into this manuscript. Available clinical results support the possibility that effects of LABA/LAMA combinations on hyperinflation, mucociliary clearance, and symptom severity may all contribute to decreasing exacerbations. While preclinical studies suggest LABAs and LAMAs have anti-inflammatory effects, such effects have not been demonstrated yet in patients with COPD.
  •  
9.
  •  
10.
  • Bellani, Giacomo, et al. (författare)
  • Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study.
  • 2017
  • Ingår i: American Journal of Respiratory and Critical Care Medicine. - 1073-449X .- 1535-4970. ; 195:1, s. 67-77
  • Tidskriftsartikel (refereegranskat)abstract
    • Rationale: Noninvasive ventilation (NIV) is increasingly used in patients with acute respiratory distress syndrome (ARDS). The evidence supporting NIV use in patients with ARDS remains relatively sparse.Objectives: To determine whether, during NIV, the categorization of ARDS severity based on the PaO2/FiO2 Berlin criteria is useful.Methods: The LUNG SAFE (Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure) study described the management of patients with ARDS. This substudy examines the current practice of NIV use in ARDS, the utility of the PaO2/FiO2 ratio in classifying patients receiving NIV, and the impact of NIV on outcome.Measurements and Main Results: Of 2,813 patients with ARDS, 436 (15.5%) were managed with NIV on Days 1 and 2 following fulfillment of diagnostic criteria. Classification of ARDS severity based on PaO2/FiO2 ratio was associated with an increase in intensity of ventilatory support, NIV failure, and intensive care unit (ICU) mortality. NIV failure occurred in 22.2% of mild, 42.3% of moderate, and 47.1% of patients with severe ARDS. Hospital mortality in patients with NIV success and failure was 16.1% and 45.4%, respectively. NIV use was independently associated with increased ICU (hazard ratio, 1.446 [95% confidence interval, 1.159–1.805]), but not hospital, mortality. In a propensity matched analysis, ICU mortality was higher in NIV than invasively ventilated patients with a PaO2/FiO2 lower than 150 mm Hg.Conclusions: NIV was used in 15% of patients with ARDS, irrespective of severity category. NIV seems to be associated with higher ICU mortality in patients with a PaO2/FiO2 lower than 150 mm Hg.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 102
Typ av publikation
tidskriftsartikel (99)
konferensbidrag (2)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (55)
övrigt vetenskapligt/konstnärligt (47)
Författare/redaktör
Larsson, Anders (15)
Hedenstierna, Göran (10)
Lange, C. (8)
Perchiazzi, Gaetano (6)
Hedenstierna, Göran, ... (6)
Janson, Christer (5)
visa fler...
Suarez-Sipmann, Fern ... (5)
Lundin, S. (4)
Duarte, R (4)
Sandström, Thomas (3)
Johansson, T (3)
Nilsson, Peter (3)
Bachert, C (3)
Fischer, A. (2)
Zhang, L. (2)
Bjermer, Leif (2)
Heinrich, J. (2)
Sandström, Thomas, 1 ... (2)
Erjefält, Jonas (2)
Kere, J (2)
Grunewald, J (2)
Larsson, K (2)
Johannessen, A. (2)
Leynaert, B. (2)
Jarvis, D. (2)
Svanes, C. (2)
Soderhall, C (2)
Melen, E (2)
Pershagen, G (2)
Franke, A (2)
Padyukov, L (2)
Eklund, A (2)
Nothen, MM (2)
Johansson, Gunnar (2)
Ekström, Magnus (2)
Ahlm, Clas (2)
Larsson, A (2)
Ställberg, Björn (2)
Tiberi, S (2)
Viiklepp, P (2)
Blomberg, Anders, 19 ... (2)
Bornefalk Hermansson ... (2)
Gualano, G (2)
Magis-Escurra, C (2)
Skrahina, A (2)
Rybicki, BA (2)
Schreiber, S (2)
Sandén, Caroline (2)
Thunström, Erik, 198 ... (2)
Lindberg, Anne (2)
visa färre...
Lärosäte
Uppsala universitet (47)
Karolinska Institutet (36)
Umeå universitet (17)
Göteborgs universitet (7)
Lunds universitet (6)
Kungliga Tekniska Högskolan (4)
visa fler...
Örebro universitet (1)
Högskolan i Borås (1)
Karlstads universitet (1)
visa färre...
Språk
Engelska (102)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (75)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy